The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy.

Saved in:
Bibliographic Details
Title: The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy.
Authors: Kim, S.1, Chen, D.T.1, Stone, B.M.2, Al-Rashdan, A.F.3, Elsaka, R.4, Torres-Roca, J.F.5, Haura, E.1, Dilling, T.J.5, Robinson, L.1, Stevens, C.W.2
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pS67-S67. 1p.
Database: Academic Search Ultimate
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2015.07.160